bromazepam Tablets 3 mg, 6 mg

Dossier type
Dossier status
Ready to file
Country of origin
GMP approvals
Manufacturer #20548
It is PIC/S certificated company, having more than 45-year experience of in manufacturing pharma products. The company is dedicated to providing superior products and services to valued clients. The company on the other hand is researching and developing new BA and BE products to meet the market trend in the future.

Manufacturer usually replies in 17 days


Bromazepam, also known by its popular brand name of Lectopam, is an anti-anxiety medication with similar therapeutic effects and side effects to diazepam (Valium). It is predominantly used in the treatment of anxiety or panic states, as such, it has become a popularly prescribed premedication before surgery. It was originally produced by the pharmaceutical products company Roche, which patented it in 1961 and got it subsequently approved for commercialization on the medical marketplace in 1974. Currently, it has entered into the generic drugs space, commonly being produced and listed for sale by Bromazepam manufacturers and Bromazepam suppliers. However, due to its psychotropic properties and frequent abuse, it is classified as a schedule IV drug in the U.S. and Canada under the Convention on Psychotropic Substances, hindering its commercialization by manufacturers. Regardless, as a generic drug, it is often found available to order on the pharmaceutical products list of distributors across the global marketplace, where it can be found wholesale at a variety of cost and price points.

Method of action of Bromazepam:

Bromazepam belongs to a group of pharmaceutical products termed benzodiazepines. Specifically, it is a lipophilic, long and intermediate-acting benzodiazepine with sedative, hypnotic, anxiolytic, and skeletal muscle relaxant properties. It functions by binding to the GABA-A receptor, producing a conformational change and causing downstream effects, which in turn culminate in the observed clinical properties. Notably, it is specific in its activation, with other neurotransmitters not being influenced.

Form and dosage of Bromazepam:

The final form and packaging of Bromazepam are dependent on the manufacturers and suppliers, as well as the specific distributors and order. However, Bromazepam can typically be found wholesale in forms including tablets, oral drops, and capsules. For the treatment of excessive anxiety in adults, the typical dose ranges from 6 mg to 18 mg daily. This can be adjusted by the prescribing medical official, up to a recommended maximum dose of a total of 30 mg daily. The length of treatment should not exceed one week unless specifically prescribed as unwanted side effects may occur. Such as dependence and withdrawal symptoms when taken for extended periods. For a complete list of possible adverse effects please refer to the manufacturers’ literature or contact the prescribing healthcare provider.

Bromazepam on Pipelinepharma:

Currently, at the time of writing, we have found 15 verified bromazepam manufacturers and bromazepam suppliers from our online global list of B2B sellers. These manufacturers, suppliers, and distributors are located globally in countries including Mexico, the European Union, Brazil, and Jordan. Every company and their pharmaceutical product list displayed on our online B2B platform has been verified by the Pipelinepharma team. This ensures seller reputability while serving to reduce souring mileage, allowing for a fluent business experience for all involved parties.

Price of Bromazepam and how to buy:

A cursory search online reveals an approximate cost for wholesale Bromazepam to be 514- 722 USD/kg from India and 1,693 USD/kg from Italy. It should be noted that these indicated values do not represent finished dosage formulations and the price of Bromazepam, as with any drug, is highly dependent on the individual situation. As such, these indicated values only serve as a generalisation of the current market condition.

Although the prices on the B2B wholesale Pipelinepharma marketplace remain confidential between both B2B parties, the seller may choose to list the desired price to facilitate the online transaction. If so, an ‘Accept’ and ‘Negotiate’ button will be displayed through the online interface, with a ‘Get offer’ button being shown in the absence.